组织陈列-产品详情

home > TISSUE ARRAYS > Multiple organ > YNB642c

Type
- FFPE
- FROZEN TISSUE
Identity
Organ
- Liver
- Esophagus
- Ovary
- Stomach
- Lung
- Colon
- Rectum
- Kidney
- Breast
- Endometrium
- Uterus
- Bladder
- Pancreas
- Skin
- Penis
- Testis
- Soft_Tissue
- Bone/Cartilage
- Oral/Cavity
- Bone/Marrow
- Heart
- Spleen
- Head/Neck
- Vulva
- Melanoma
- Appendix
- Intestine
- Adrenal Gland
- Thymus
- Fallopian tube
- Mouse
- Fetus
- Rat
- Monkey (Rhesus) (Normal)-RsFPT
- Monkey (Cynomolgus) (Normal)-CyFPT
- Dog
- Multiple organ
- Gall bladder and bile duct
- Esophagogastric junction
Types/Disease
Cores
Cases

Cores:

64

CASES:

32

Core Diameter(mm):

2

Thickness(µm):

5

Row number:

7

Column number:

10

Tissue Array Type:

FFPE

Species:

Human

YNB642c

$255.00

Description: Neuroblastoma and peripheral nerve tissue array, including TNM and INSS stage, 32 cases/64 cores, replacing NB642b

Details: Neuroblastoma and peripheral nerve tissue microarray, containing 27 cases of neuroblastoma, plus 5 peripheral nerve tissue, duplicate cores per case

Applications: Routine histology procedures including Immunohistochemistry (IHC) and In Situ Hybridization (ISH), protocols which can be found at our support page

Please Select Tissue Array Type:

Unstained

H&E

Tag:

Add To Cart

Outright purchase

Note

1. TMA slides were sectioned and stored at 4°C and may not be fresh cut, but still suitable for IHC. Please request fresh cut if experiment involves phospho-specific antibodies, RNA studies, FISH or ISH, etc. A minimum of 3 slides per TMA must be purchased to cover the cost of trimming for fresh sectioning.
2. Most TMA slides were not coated with an extra layer of paraffin (tissue cores can be easily seen on the glass). To prevent tissue detachment during antigen retrieval, unbaked slides must be baked for at least 30 to 120 minutes at 60°C. before putting into xylene for de-paraffinization. Baked slides were sent out baked for 2 hours.
In the following specsheet,“*” means invalid core; “-” means no applicable or negative in IHC markers."

Specification sheet
Overlapping case
Download specifications

Legend:

Car-Cardia Eso-Fsophagus

Malignant(IIII)
Normal(*)
Malignant(I)
Malignant(II)
Malignant(III)

TISSUE ARRAYS
YNB642c

	1	2	3	4	5	6	7	8	9	10
A	Adr	Adr	Adr	Adr	Adr	Adr	Pel	Pel	Med	Med
B	Med	Med	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
C	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
D	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
E	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
F	Med	Med	Ret	Ret	Ner	Ner	Ner	Ner	Ner	Ner
G	Ner	Ner	Ner	Ner

YNB642c

Age:
Sex:
Organ/Anatomic Site:
Pathology diagnosis:
Grade:
TNM:
Stage:
Tissue ID.:
Type:

Pos	No.	Age	Sex	Organ/Anatomic Site	Pathology diagnosis	Grade	TNM	Stage	Type	Ki-67	SYN
A1	1	20	M	Adrenal gland	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
A2	2	20	M	Adrenal gland	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
A3	3	5	F	Adrenal gland	Neuroblastoma with necrosis (sparse)	*	T1N0M0	I	Malignant	-	-
A4	4	5	F	Adrenal gland	Neuroblastoma with necrosis	*	T1N0M0	I	Malignant	-	-
A5	5	6	M	Adrenal gland	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
A6	6	6	M	Adrenal gland	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
A7	7	25	F	Pelvic cavity	Neuroblastoma	*	T3N0M0	IIII	Malignant	-	-
A8	8	25	F	Pelvic cavity	Neuroblastoma	*	T3N0M0	IIII	Malignant	-	-
A9	9	2	F	Mediastinum	Neuroblastoma	*	T1N0M0	I	Malignant	-	+
A10	10	2	F	Mediastinum	Neuroblastoma	*	T1N0M0	I	Malignant	+5%	+
B1	11	51	M	Mediastinum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
B2	12	51	M	Mediastinum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
B3	13	3	F	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	-	-
B4	14	3	F	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	+30%	-
B5	15	1	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	+5%	-
B6	16	1	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	+3%	-
B7	17	18	M	Retroperitoneum	Neuroblastoma	*	T2N1M0	III	Malignant	+20%	-
B8	18	18	M	Retroperitoneum	Neuroblastoma	*	T2N1M0	III	Malignant	+15%	-
B9	19	8	F	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
B10	20	8	F	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
C1	21	7	M	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
C2	22	7	M	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
C3	23	4	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
C4	24	4	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
C5	25	6	M	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	+5%	-
C6	26	6	M	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	+5%	-
C7	27	26	F	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
C8	28	26	F	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
C9	29	4	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
C10	30	4	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
D1	31	3	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
D2	32	3	F	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	-	-
D3	33	1	F	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	+3%	-
D4	34	1	F	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	+8%	-
D5	35	2	F	Retroperitoneum	Neuroblastoma	*	T3N1M0	III	Malignant	-	-
D6	36	2	F	Retroperitoneum	Neuroblastoma	*	T3N1M0	III	Malignant	-	-
D7	37	5	M	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	+5%	++
D8	38	5	M	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	+5%	++
D9	39	8 Mon.	M	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	-	-
D10	40	8 Mon.	M	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	+5%	-
E1	41	1	M	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	-	+
E2	42	1	M	Retroperitoneum	Neuroblastoma	*	T3N0M0	III	Malignant	+15%	+
E3	43	27	M	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	+10%	+
E4	44	27	M	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	+15%	+
E5	45	4	M	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
E6	46	4	M	Retroperitoneum	Neuroblastoma	*	T1N0M0	I	Malignant	-	-
E7	47	4	F	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	+10%	-
E8	48	4	F	Retroperitoneum	Neuroblastoma	*	T2N0M0	II	Malignant	-	-
E9	49	84	M	Retroperitoneum	Neuroblastoma (fibrous tissue)	*	T3N1M0	III	Malignant	-	-
E10	50	84	M	Retroperitoneum	Neuroblastoma	*	T3N1M0	III	Malignant	-	-
F1	51	1	F	Mediastinum	Neuroblastoma	*	T2N0M0	II	Malignant	-	-
F2	52	1	F	Mediastinum	Neuroblastoma	*	T2N0M0	II	Malignant	-	-
F3	53	5	M	Retroperitoneum	Neuroblastoma with necrosis	*	T2N1M0	I	Malignant	-	++
F4	54	5	M	Retroperitoneum	Neuroblastoma with necrosis	*	T2N1M0	I	Malignant	-	++
F5	55	32	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
F6	56	32	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
F7	57	34	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
F8	58	34	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
F9	59	35	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
F10	60	35	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
G1	61	30	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
G2	62	30	M	Nerve	Peripheral nerve tissue (adipose tissue)	*	*	*	Normal	-	-
G3	63	35	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-
G4	64	35	M	Nerve	Peripheral nerve tissue	*	*	*	Normal	-	-

Find overlapping cases with this tissue array:

YNB642c

File Format: .xlsx

Release Date: 2025-01-17 16:14:19
Download

	1	2	3	4	5	6	7	8	9	10
A	Adr	Adr	Adr	Adr	Adr	Adr	Pel	Pel	Med	Med
B	Med	Med	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
C	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
D	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
E	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
F	Med	Med	Ret	Ret	Ner	Ner	Ner	Ner	Ner	Ner
G	Ner	Ner	Ner	Ner

	1	2	3	4	5	6	7	8	9	10
A	Adr	Adr	Adr	Adr	Adr	Adr	Pel	Pel	Med	Med
B	Med	Med	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
C	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
D	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
E	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
F	Med	Med	Ret	Ret	Ner	Ner	Ner	Ner	Ner	Ner
G	Ner	Ner	Ner	Ner

	1	2	3	4	5	6	7	8	9	10
A	Adr	Adr	Adr	Adr	Adr	Adr	Pel	Pel	Med	Med
B	Med	Med	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
C	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
D	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
E	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret	Ret
F	Med	Med	Ret	Ret	Ner	Ner	Ner	Ner	Ner	Ner
G	Ner	Ner	Ner	Ner